May 10, 2018 / 12:15 PM / 12 days ago

BRIEF-Corbus Pharmaceuticals Reports Q1 Loss Per Share $0.21

May 10 (Reuters) - Corbus Pharmaceuticals Holdings Inc :

* CORBUS PHARMACEUTICALS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* CORBUS PHARMACEUTICALS HOLDINGS INC Q1 SHR LOSS $0.21

* CORBUS PHARMACEUTICALS HOLDINGS INC Q1 SHR VIEW $-0.14 — THOMSON REUTERS I/B/E/S

* CORBUS PHARMACEUTICALS HOLDINGS INC - EXPECTS TO REPORT TOPLINE RESULTS FOR PHASE 2B CF STUDY IN FIRST HALF OF 2020.

* CORBUS PHARMACEUTICALS - EXPECTS CURRENT CASH AND CASH EQUIVALENTS WITH OTHER PAYMENTS TO FUND OPERATIONS THROUGH Q4 2019

* CORBUS PHARMACEUTICALS HOLDINGS INC - ENDED Q1 WITH APPROXIMATELY $71.0 MLN OF CASH AND CASH EQUIVALENTS

* CORBUS PHARMACEUTICALS HOLDINGS INC - REVENUE FOR QUARTER DECREASED BY APPROXIMATELY $0.3 MLN TO $1.0 MLN FROM QUARTER ENDED MARCH 31, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below